Fig. 2
From: Disease modification and Neuroprotection in neurodegenerative disorders
Biomarkers of neurodegenerative disorders (a) and of Alzheimer’s disease (b). The exact order of the cascade of events from Aß production to cell death is not fully determined (Aß – amyloid ß protein; AD – Alzheimer’s disease; ASL – arterial spin labeling; DTI – diffusion tensor imaging; FDG – fluoroeoxyglucose; fMRI functional magnetic resonance imaging; NF-L – neurofilament light; PET – positron emission tomography; p-tau – phosphorylated tau protein; Q-EEG – quantitative electroencephalography; SILK – stable isotope-labeled kinetics). *The regional pattern of these changes may be specific to the neurodegenerative disease